DK0557244T3 - Dosisformer med forlænget afgivelse af aktivt stof - Google Patents

Dosisformer med forlænget afgivelse af aktivt stof

Info

Publication number
DK0557244T3
DK0557244T3 DK93810066.6T DK93810066T DK0557244T3 DK 0557244 T3 DK0557244 T3 DK 0557244T3 DK 93810066 T DK93810066 T DK 93810066T DK 0557244 T3 DK0557244 T3 DK 0557244T3
Authority
DK
Denmark
Prior art keywords
dosage forms
weight
active substance
prolonged release
calcium antagonist
Prior art date
Application number
DK93810066.6T
Other languages
Danish (da)
English (en)
Inventor
Sabine Compassi
Original Assignee
Siegfried Ag Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag Pharma filed Critical Siegfried Ag Pharma
Application granted granted Critical
Publication of DK0557244T3 publication Critical patent/DK0557244T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DK93810066.6T 1992-02-17 1993-02-03 Dosisformer med forlænget afgivelse af aktivt stof DK0557244T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46992 1992-02-17

Publications (1)

Publication Number Publication Date
DK0557244T3 true DK0557244T3 (da) 1996-04-01

Family

ID=4187725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93810066.6T DK0557244T3 (da) 1992-02-17 1993-02-03 Dosisformer med forlænget afgivelse af aktivt stof

Country Status (6)

Country Link
EP (1) EP0557244B1 (de)
AT (1) ATE135214T1 (de)
DE (1) DE69301742T2 (de)
DK (1) DK0557244T3 (de)
ES (1) ES2084478T3 (de)
GR (1) GR3019314T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
NZ286451A (en) * 1996-04-24 1998-04-27 Bernard Charles Sherman Controlled release pharmaceutical composition containing granules comprising drug, water-insoluble polymer and meltable carrier
FR2901611B1 (fr) * 2006-05-24 2009-01-16 Airbus France Sas Dispositif de controle non destructif d'une piece par analyse de distribution du champ magnetique de fuite

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung

Also Published As

Publication number Publication date
DE69301742T2 (de) 1996-08-14
ATE135214T1 (de) 1996-03-15
EP0557244B1 (de) 1996-03-13
DE69301742D1 (de) 1996-04-18
GR3019314T3 (en) 1996-06-30
EP0557244A1 (de) 1993-08-25
ES2084478T3 (es) 1996-05-01

Similar Documents

Publication Publication Date Title
RU93004469A (ru) Формы дозирования, обеспечивающие продленное выделение активного ингредиента
DE69523438D1 (de) Orale metoprolol-dosisform des typs "einmal täglich"
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
EP2103303A3 (de) Tramadolhaltige Formulierung mit gesteuerter Freisetzung
CA2131350A1 (en) Sustained release drug formulation containing a tramadol salt
HU0200688D0 (en) Pharmaceutical formulations with improved release containing solid salts of racemic thioctic acid
IL96900A0 (en) Pharmaceutical composition containing naproxen
MX9300664A (es) Formas de dosis farmaceuticas que contienen liberacion prolongada de ingrediente activo.
DK1001772T3 (da) Forbedret afgivelse af flere doser af et medikament
NZ311145A (en) Controlled release formulations containing a poorly soluble drug in a solid dispersion with a hydrophilic poloxamer
NO944001D0 (no) Farmasöytisk preparat inneholdende diklormetylenbisfofonsyre eller salt derav for oral tilförsel
ATE430561T1 (de) Chronotherapeutische diltiazem formulierungen und deren verabreichung
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
DK0557244T3 (da) Dosisformer med forlænget afgivelse af aktivt stof
DE69209916T2 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
EP0761209A3 (de) Ranitidinformulierungen mit gesteuerter Freisetzung
ATE165599T1 (de) Benzospiroalken-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69416034T2 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen